BRIEF-Contravir Pharmaceuticals enters into amended, restated executive agreement with James Sapirstein, CFO
May 26, 2017 at 17:45 PM EDT
* On May 25 entered into amended,restated executive agreement with James Sapirstein, chief executive officer - SEC filing